Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

计划入组 60 人 · 首次发布于 2023 年 4 月 18 日

Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea

计划入组 35 人 · 首次发布于 2017 年 2 月 8 日

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

计划入组 20 人 · 首次发布于 2024 年 1 月 2 日

non-mutagenic extracellular therapeutic agent (osteoporosis)

non-mutagenic extracellular therapeutic agent (rare diseases)

non-erythropoietic cytokine

The Cooper Health System, A New Jersey Non-Profit Corporation

United States

REPLIGEN CORPORATION

United States

EMCURE PHARMACEUTICALS LIMITED

United Arab Emirates

EMA Issues Updated Guidance on Non-Mutagenic Impurity Qualification to Reduce Animal Testing

ICH Opens Public Consultation on Draft Q3E Guideline for Extractables and Leachables in Drug Products

EpiVax and FDA Scientists Identify Immunogenicity Risks in Generic Teriparatide Impurities